News and Announcements
YPB Patent for Smartphone that Will Be Connectable to Scanner
- Published March 15, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Brand Protection and Customer Engagement solutions Company YPB Group Ltd (ASX: YPB) is pleased to announce that is has received notification from the US Patent office of the publication. The publication of a Patent application marks the date at which it is publicly available and, therefore, at which it forms full prior art for other Patent applications worldwide.
KEY TAKEAWAYS:
- USA Patent enhances previously granted China Patent for “On the Go” or “OTG” scanner.
- Extends interface to “Bluetooth” and other wireless connections to mobile smartphones as well as USB connectivity.
This Patent extends the scanner utility Patent granted on 17th February 2016 by China’s SIPO. This USA Patent application extends the protection of the China SIPO Patent to include wireless connectivity capabilities for YPB’s scanner technology – most immediately, to enable the scanner to connect to smartphones via, for example, Bluetooth as well as USB connectivity.
YPB Executive Chairman John Houston said: “Building an Intellectual Property portfolio has been a strategy since inception and the milestone of having the earlier China Patent extended to the USA is valuable for YPB and our customers. YPB believes in a world where products can be scanned using smartphones as a convenient means of product authentication and a trigger for valuable customer engagement.”
YPB Group (ASX: YPB) is a pioneer in advanced brand protection solutions. Listed on the Australian Securities Exchange, YPB is expanding its global footprint with an established presence in Australia, China, Thailand, USA, and Mexico.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
